Simvastatin Production Cost Reports

The report provides a detailed analysis essential for establishing a Simvastatin production plant. It encompasses all critical aspects necessary for Simvastatin production, including the cost of Simvastatin production, Simvastatin plant cost, Simvastatin production costs, and the overall Simvastatin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Simvastatin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Simvastatin is an antihyperlipidemic medication used as a pharmaceutical drug used to lower cholesterol levels and prevent cardiovascular diseases. It is a leading cholesterol-lowering drug, specifically an HMG-CoA reductase inhibitor, used to treat hypercholesterolemia and associated cardiovascular risks such as heart attack and stroke. The drug originated as a semi-synthetic derivative of lovastatin. The drug's use is predominantly in lipid control and prevention of atherosclerosis-related complications.

The market demand for Simvastatin is driven by its role in managing cardiovascular health by lowering cholesterol levels. The global pharmaceutical industry's expansion, alongside the increasing prevalence of lifestyle-related diseases such as obesity, diabetes, and hypertension, drives demand for Simvastatin as these conditions elevate the risk of cardiovascular diseases. Factors such as ageing populations and greater health awareness globally, especially in emerging markets like the Asia Pacific, further fuel demand. Additionally, its availability as a cost-effective, well-established statin widely prescribed for both primary and secondary prevention of cardiovascular complications boosts its market growth. Moreover, growing public focus on preventive healthcare and broader access to affordable generics support market growth.

The market is also driven by innovations like combination therapies and advanced drug delivery systems. Industrial simvastatin procurement is impacted by the costs and availability of the raw materials, such as lovastatin derivatives and speciality reagents used in its production. Procurement decisions are tightly linked to manufacturers' compliance with strict quality standards, certifications (e.g., GMP), and process innovations like green chemistry. Additionally, regulatory approvals and post-marketing safety surveillance impose ongoing cost and operational burdens. Generic competition and intense price sensitivity further affect procurement pricing strategies.

Raw Material for Simvastatin Production

According to the Simvastatin production plant project report, the raw material for Simvastatin production includes Lovastatin.

Production Process of Simvastatin

The extensive Simvastatin production cost report consists of the following major industrial production process:

1. Production via a multistep semi-synthetic process: The production process of Simvastatin from Lovastatin involves a multistep semi-synthetic process where the 2-methylbutyryl side chain of Lovastatin is replaced by a 2,2-dimethylbutyryl group. The method begins with hydrolysing Lovastatin to produce monacolin J, which is then protected at specific hydroxyl groups via lactonisation and trimethylsilylation. This protected intermediate undergoes acylation with α-dimethylbutyryl chloride, followed by deprotection to yield Simvastatin.

Properties of Simvastatin

Simvastatin is a white to almost white solid powder with the molecular formula C25H38O5 and a molecular weight of 418.57 g/mol. It is a lipophilic compound with a high logP value (4.68 to 4.85), indicating low solubility in water but good solubility in organic solvents such as chloroform. Its melting point ranges between 132 to 137 degree Celsius. Simvastatin is air-sensitive and hygroscopic, and it is recommended to be stored at room temperature in a cool, dark place, preferably under inert gas to maintain stability.

It has a specific optical rotation between +285 to +300 degrees (measured in acetonitrile). It is a delta-lactone and a semi-synthetic statin derived from Lovastatin with characteristic ester and hydroxyl functional groups. Due to its low water solubility, the drug exhibits limited bioavailability, which influences pharmaceutical formulation strategies. Simvastatin is chemically stable but requires protection from moisture and light for long shelf life.